主题：【悬赏帖】求助5篇英文，剩2篇，再努力！

1. GSK-3 Inhibitors: Discoveries and Developments

Author(s): M. Alonso and A. Martinez
Affiliation: NeuroPharma, S.A.; Avda. De la Industria 52, 28760 Tres Cantos, Madrid, Spain.
- See more at: http://www.eurekaselect.com/61839/article?trendmd-shared=0#sthash.g4m4RuEA.dpuf
2. The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases
Author(s): Amar S., Belmaker R.H. and Agam G.
Affiliation: Beer-Sheba Mental Health Center PO Box 4600, Beer-Sheba ISRAEL.
- See more at: http://www.eurekaselect.com/74966/article#sthash.JDwG8T1e.dpuf
3. Structure-Based Approaches in the Design of GSK-3 Selective Inhibitors
Author(s): Dhilon S. Patel, Nigus Dessalew, Pansy Iqbal and Prasad V. Bharatam
Affiliation: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali) - 160 062, Punjab, India.
- See more at: http://www.eurekaselect.com/78567/article?trendmd-shared=0#sthash.hW02mw4r.dpuf
4. Exploiting Substrate Recognition for Selective Inhibition of Protein Kinases
Author(s): Avital Licht-Murava and Hagit Eldar-Finkelman
Affiliation: Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
- See more at: http://www.eurekaselect.com/98470/article?trendmd-shared=0#sthash.jKbAUWDl.dpuf
5. Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Author(s): Lisa Kockeritz, Bradley Doble, Satish Patel and James R. Woodgett
Affiliation: Samuel Lunenfeld Research Institute, 600 University Avenue, Ontario M5G 1X5, Canada.

- See more at: http://www.eurekaselect.com/58133/article?trendmd-shared=0#sthash.PKemuRlI.dpuf